Cargando…
Seroprevalence of antibodies to herpes simplex virus 1 and 2 in patients with HIV positive from Ebonyi State, Nigeria: a cross-sectional study
OBJECTIVES: To assess the seroprevalence of herpes simplex virus (HSV) types 1 and 2 in patients infected with HIV in Nigeria. DESIGN: Cross-sectional design from January to June 2019. SETTING: Federal Teaching Hospital, Ebonyi State, Nigeria. PARTICIPANTS: A total of 276 patients with HIV were anal...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124271/ https://www.ncbi.nlm.nih.gov/pubmed/37072358 http://dx.doi.org/10.1136/bmjopen-2022-069339 |
_version_ | 1785029804285755392 |
---|---|
author | Onu, Euslar Nnenna Ekuma, Uchechukwu Onyeukwu Judi, Hawraa K Ogbu, Ogbonnaya Okoro, Nworie Ajugwo, Gloria C Akrami, Sousan Okoli, Chukwudum S Anyanwu, Chioma Ngozi Saki, Morteza Edeh, Peter Anyigor |
author_facet | Onu, Euslar Nnenna Ekuma, Uchechukwu Onyeukwu Judi, Hawraa K Ogbu, Ogbonnaya Okoro, Nworie Ajugwo, Gloria C Akrami, Sousan Okoli, Chukwudum S Anyanwu, Chioma Ngozi Saki, Morteza Edeh, Peter Anyigor |
author_sort | Onu, Euslar Nnenna |
collection | PubMed |
description | OBJECTIVES: To assess the seroprevalence of herpes simplex virus (HSV) types 1 and 2 in patients infected with HIV in Nigeria. DESIGN: Cross-sectional design from January to June 2019. SETTING: Federal Teaching Hospital, Ebonyi State, Nigeria. PARTICIPANTS: A total of 276 patients with HIV were analysed using ELISA method for the presence of HSV-1 and HSV-2 specific IgG antibodies. OUTCOMES: Fisher’s exact test was used to determine the association between the seroprevalence of HSV and demographic variables (statistically significant=p value ≤0.05). RESULTS: Totally, 212 (76.8%) and 155 (56.2%) patients with HIV were seropositive for HSV-1 and HSV-2 IgG antibodies, respectively. The seroprevalence of HSV-1 was significantly higher than the HSV-2 in patients with HIV (p value <0.0001). HSV-1 and HSV-2 seroprevalence were higher in patients aged more than 30 years. The seroprevalence of HSV-1 was significantly higher (p=0.01) in females (82.4%, 131/159) than males (69.2%, 81/117), but there was no significant difference in seroprevalence of HSV-2 in females (57.9%, 92/159) compared with males (53.8%, 63/117) (p=0.51). Professional drivers had a higher seroprevalence of HSV-1 and HSV-2 and there was a significant association between the occupation and the HSV-1 and HSV-2 seropositivity (p>0.05). The seroprevalence of HSV-1 was significantly higher in the singles (87.4%, 90/103) than the married patients with HIV (p=0.001). However, HSV-2 seroprevalence was significantly higher in the married patients with HIV (63.6%, 110/173) (p=0.001). CONCLUSIONS: Prevalence of 76.8% for HSV-1 and 56.2% for HSV-2 among patients with HIV was seen. The HSV-1 was significantly higher in the singles while HSV-2 seroprevalence was significantly higher in the married patients with HIV with HSV-1 and HSV-2 coinfection rate of 7.6%. This study became very imperative to provide an important insight into the hidden dynamics of HSV infections. |
format | Online Article Text |
id | pubmed-10124271 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-101242712023-04-25 Seroprevalence of antibodies to herpes simplex virus 1 and 2 in patients with HIV positive from Ebonyi State, Nigeria: a cross-sectional study Onu, Euslar Nnenna Ekuma, Uchechukwu Onyeukwu Judi, Hawraa K Ogbu, Ogbonnaya Okoro, Nworie Ajugwo, Gloria C Akrami, Sousan Okoli, Chukwudum S Anyanwu, Chioma Ngozi Saki, Morteza Edeh, Peter Anyigor BMJ Open HIV/AIDS OBJECTIVES: To assess the seroprevalence of herpes simplex virus (HSV) types 1 and 2 in patients infected with HIV in Nigeria. DESIGN: Cross-sectional design from January to June 2019. SETTING: Federal Teaching Hospital, Ebonyi State, Nigeria. PARTICIPANTS: A total of 276 patients with HIV were analysed using ELISA method for the presence of HSV-1 and HSV-2 specific IgG antibodies. OUTCOMES: Fisher’s exact test was used to determine the association between the seroprevalence of HSV and demographic variables (statistically significant=p value ≤0.05). RESULTS: Totally, 212 (76.8%) and 155 (56.2%) patients with HIV were seropositive for HSV-1 and HSV-2 IgG antibodies, respectively. The seroprevalence of HSV-1 was significantly higher than the HSV-2 in patients with HIV (p value <0.0001). HSV-1 and HSV-2 seroprevalence were higher in patients aged more than 30 years. The seroprevalence of HSV-1 was significantly higher (p=0.01) in females (82.4%, 131/159) than males (69.2%, 81/117), but there was no significant difference in seroprevalence of HSV-2 in females (57.9%, 92/159) compared with males (53.8%, 63/117) (p=0.51). Professional drivers had a higher seroprevalence of HSV-1 and HSV-2 and there was a significant association between the occupation and the HSV-1 and HSV-2 seropositivity (p>0.05). The seroprevalence of HSV-1 was significantly higher in the singles (87.4%, 90/103) than the married patients with HIV (p=0.001). However, HSV-2 seroprevalence was significantly higher in the married patients with HIV (63.6%, 110/173) (p=0.001). CONCLUSIONS: Prevalence of 76.8% for HSV-1 and 56.2% for HSV-2 among patients with HIV was seen. The HSV-1 was significantly higher in the singles while HSV-2 seroprevalence was significantly higher in the married patients with HIV with HSV-1 and HSV-2 coinfection rate of 7.6%. This study became very imperative to provide an important insight into the hidden dynamics of HSV infections. BMJ Publishing Group 2023-04-18 /pmc/articles/PMC10124271/ /pubmed/37072358 http://dx.doi.org/10.1136/bmjopen-2022-069339 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | HIV/AIDS Onu, Euslar Nnenna Ekuma, Uchechukwu Onyeukwu Judi, Hawraa K Ogbu, Ogbonnaya Okoro, Nworie Ajugwo, Gloria C Akrami, Sousan Okoli, Chukwudum S Anyanwu, Chioma Ngozi Saki, Morteza Edeh, Peter Anyigor Seroprevalence of antibodies to herpes simplex virus 1 and 2 in patients with HIV positive from Ebonyi State, Nigeria: a cross-sectional study |
title | Seroprevalence of antibodies to herpes simplex virus 1 and 2 in patients with HIV positive from Ebonyi State, Nigeria: a cross-sectional study |
title_full | Seroprevalence of antibodies to herpes simplex virus 1 and 2 in patients with HIV positive from Ebonyi State, Nigeria: a cross-sectional study |
title_fullStr | Seroprevalence of antibodies to herpes simplex virus 1 and 2 in patients with HIV positive from Ebonyi State, Nigeria: a cross-sectional study |
title_full_unstemmed | Seroprevalence of antibodies to herpes simplex virus 1 and 2 in patients with HIV positive from Ebonyi State, Nigeria: a cross-sectional study |
title_short | Seroprevalence of antibodies to herpes simplex virus 1 and 2 in patients with HIV positive from Ebonyi State, Nigeria: a cross-sectional study |
title_sort | seroprevalence of antibodies to herpes simplex virus 1 and 2 in patients with hiv positive from ebonyi state, nigeria: a cross-sectional study |
topic | HIV/AIDS |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124271/ https://www.ncbi.nlm.nih.gov/pubmed/37072358 http://dx.doi.org/10.1136/bmjopen-2022-069339 |
work_keys_str_mv | AT onueuslarnnenna seroprevalenceofantibodiestoherpessimplexvirus1and2inpatientswithhivpositivefromebonyistatenigeriaacrosssectionalstudy AT ekumauchechukwuonyeukwu seroprevalenceofantibodiestoherpessimplexvirus1and2inpatientswithhivpositivefromebonyistatenigeriaacrosssectionalstudy AT judihawraak seroprevalenceofantibodiestoherpessimplexvirus1and2inpatientswithhivpositivefromebonyistatenigeriaacrosssectionalstudy AT ogbuogbonnaya seroprevalenceofantibodiestoherpessimplexvirus1and2inpatientswithhivpositivefromebonyistatenigeriaacrosssectionalstudy AT okoronworie seroprevalenceofantibodiestoherpessimplexvirus1and2inpatientswithhivpositivefromebonyistatenigeriaacrosssectionalstudy AT ajugwogloriac seroprevalenceofantibodiestoherpessimplexvirus1and2inpatientswithhivpositivefromebonyistatenigeriaacrosssectionalstudy AT akramisousan seroprevalenceofantibodiestoherpessimplexvirus1and2inpatientswithhivpositivefromebonyistatenigeriaacrosssectionalstudy AT okolichukwudums seroprevalenceofantibodiestoherpessimplexvirus1and2inpatientswithhivpositivefromebonyistatenigeriaacrosssectionalstudy AT anyanwuchiomangozi seroprevalenceofantibodiestoherpessimplexvirus1and2inpatientswithhivpositivefromebonyistatenigeriaacrosssectionalstudy AT sakimorteza seroprevalenceofantibodiestoherpessimplexvirus1and2inpatientswithhivpositivefromebonyistatenigeriaacrosssectionalstudy AT edehpeteranyigor seroprevalenceofantibodiestoherpessimplexvirus1and2inpatientswithhivpositivefromebonyistatenigeriaacrosssectionalstudy |